Peak Rock affiliate completes acquisition of Paragon Healthcare

An affiliate of middle-market private equity firm Peak Rock Capital (Peak Rock) has completed its acquisition of Paragon Healthcare (Paragon) in partnership with the management team of the Company.

Paragon is a leading provider of ambulatory and home infusion services and specialty pharmacy services. The Company provides comprehensive, high quality infusion services to patients with chronic health conditions and those in need of post-acute care. Headquartered in Dallas, Texas, with pharmacy and infusion operations in Alabama, Georgia, Tennessee, Louisiana, Texas, Oklahoma, Colorado, Oregon, and Washington, the Company has built an excellent reputation in the industry for its service to patients across lower-cost settings of care, including infusion centres, patient homes, and physician’s offices.

Spencer Moore, Managing Director of Peak Rock, says: “The Paragon team has an impressive track-record of rapidly growing its infusion services to patients across multiple, low-cost settings of care. We are excited to partner with Paragon management and employees in supporting the Company’s continued strong growth in high quality patient care through organic initiatives and strategic acquisitions.”

“We believe our partnership with Peak Rock will help Paragon continue its mission of providing patients with high quality, convenient, comfortable, and lower cost infusion and specialty pharmacy services, as well as facilitate continued growth in access to lower cost care,” says Rick Allen, co-founder and Chief Executive Officer of Paragon.

Steve Martinez, President and Managing Director of Peak Rock, says: “Paragon and its employees have a tremendous reputation for high quality patient care, and we’re thrilled to partner with the team to further invest in geographic expansion and other tools to support the Company’s rapid growth.”

Anthony DiSimone, Chief Executive Officer of Peak Rock, adds: “This transaction is another example of Peak Rock’s deep experience in providing first time institutional capital to companies with significant growth potential.  It also highlights our continuing efforts to expand our investment activity into resilient businesses in the healthcare sector.”